
NuVasive NUVA
Quartalsbericht 2023-Q2
hinzugefügt 02.08.2023
NuVasive Gesamtverbindlichkeiten 2011-2026 | NUVA
Gesamtverbindlichkeiten Jährlich NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 970 M | 873 M | 840 M | 870 M | 587 M | 695 M | 575 M | 626 M | 619 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 970 M | 575 M | 740 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
52 M | $ 3.89 | 6.06 % | $ 160 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.17 | 0.6 % | $ 156 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 7.27 | -3.32 % | $ 1.09 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.21 | -0.68 % | $ 1.34 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.71 | -0.56 % | $ 415 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.51 | -2.3 % | $ 65.9 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 12.41 | -3.2 % | $ 351 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.61 | 0.16 % | $ 38 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 72.24 | 0.53 % | $ 3.94 B | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 11.56 | 0.7 % | $ 414 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.72 | 0.6 % | $ 464 M | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
27.2 M | $ 0.83 | -0.82 % | $ 34.7 M | ||
|
Electromed
ELMD
|
10.6 M | $ 26.97 | -0.33 % | $ 228 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.18 | 0.36 % | $ 885 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
11 M | $ 6.98 | 1.82 % | $ 211 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 152.77 | -0.9 % | $ 10.7 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
730 M | $ 79.44 | 2.08 % | $ 10.7 B | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.37 | 0.4 % | $ 6.57 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.37 | -1.05 % | $ 1.13 B | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 283.81 | -0.57 % | $ 108 B | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 44.68 | 0.95 % | $ 1.31 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 87.68 | -0.48 % | $ 3.05 B | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 78.93 | -1.26 % | $ 46.2 B | ||
|
TransMedics Group
TMDX
|
595 M | $ 66.89 | -1.33 % | $ 2.27 B |